Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2013PLoS ONEOpen Access

A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix® and Gardasil® Human Papillomavirus Vaccines in 12-15 Year Old Girls

View Full Paper
Ask AI
Bookmark
Share

Authors

EDEve DraperSBSara L. BissettLondon School of Hygiene & Tropical MedicineRHRebecca Howell‐JonesBirmingham City Council

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Draper et al. (2013) studied this question.

synapsesocial.com/papers/6a8201d6adfa6baaaee20203https://doi.org/10.1371/journal.pone.0061825
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection1995 · 592 citations
  2. 2Antibodies from Women Immunized with Gardasil ® Cross-Neutralize HPV 45 Pseudovirions2007 · 137 citations
  3. 3Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication2010 · 1,075 citations
  4. 4Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18–45 years2011 · 114 citations
  5. 5Long term protection against cervical infection with the human papillomavirus: Review of currently available vaccines2011 · 125 citations